G Medical Innovations IPO Presentation Deck
Board of Directors
G
Dr. Kenneth R. Melani Non-Executive Chairman, began his career in 1981 as a practicing physician growing his internal medicine practice into the
largest multi-specialty physician practice in Western Pennsylvania. In the mid 1980's he helped start a physician hospital organization, West Penn Cares,
where he became the CEO. In this role he prepared for managed care risk sharing contracts (known as ACO's today). In addition, he started seven successful
for-profit health services businesses. In 1989 he joined Highmark Inc where he spent the next 23 years of his career in a variety of positions including Chief
Medical Officer, President of Health-Related Services, and EVP, Strategy and New Business Development. In 2003, he was named the President and CEO of
Highmark Inc. During his nine- and half-year tenure he grew the company into one of the largest and most diversified health care companies in the United
States, serving over 32 million individuals.
Professor Zeev Rotstein Non-Executive Director, Prof. Rotstein MD MHA, trained in medicine at Tel Aviv University. He has held several fellowships
abroad: at the New York Department of Health, Tufts University, and Johns Hopkins Medical Centre, including the School of Hygiene and Public Health. He is an
internationally recognized cardiologist and expert in health care management systems, with decades of experience serving as the Director General of both Sheba and
Hadassah Medical Organization, Associate Clinical Professor in both Tel Aviv and the Hebrew Universities. Currently, Professor Rostein is a consultant in the field
of Health Care management, construction of medical facilities throughout the world and developing innovative medical technologies.
Dr. Shuki Gleitman Non-Executive Director, is the Chairman of the Guangzhuo Israel Biotech Fund, Chairman of the Board of Directors of Capital Point
Group, a Board member and Chairman of the audit and financial committees of Elbit Systems (NASDAQ, TLV traded), Chairman of the YoYa Group, Senior Advisor
to the World Bank (national policy for innovation) and Senior Strategy Advisor to Serbia Innovation Fund. Prior to holding the positions set out above, Dr. Gleitman
was the Chief Scientist and Director General of Israel's Ministry of Industry and Trade, where he managed Israeli Government technological programs. Dr. Gleitman
also served as the CEO of Ampal Investment Group (Nasdaq: AMPL), where he was responsible for the investment of over $200 million in high-tech ventures.
During his tenure at Ampal, Dr. Gleitman led a $330 million joint venture with Motorola Israel founding Mirs Communications Ltd., Israel's fourth largest cellular
operator. Dr. Gleitman holds a Ph.D. (with distinction), M.Sc. (with distinction) and B.Sc. in Physical Chemistry, from the Hebrew University of Jerusalem.
Urs Wettstein Non-Executive Director, was an advisor and investor in numerous pre- IPO investments since 1985 and was instrumental for several
successful IPO's in Switzerland. He operated his own accounting, auditing and tax consultancy firm in Zurich, Switzerland from 1983 to 2007. From 1976 to 1982,
he was an auditor and tax consultant with Coopers & Lybrand AG, Zurich. Urs Wettstein graduated as a Certified Public Accountant. From 2001 to 2014 he served
as non-executive Vice Chairman of the Board of Directors of LifeWatch AG, a company listed on the Swiss Stock Exchange.
19View entire presentation